From: Development of a pharmaceutical care program in progressive stages in geriatric institutions
Drug related problems detected | HSS | EAR |
---|---|---|
PROBLEMS ARE ARISING FROM THE FINANCIAL IMPACT OF THERAPY | 14,2 | 6,9 |
CONDITION FOR WHICH NO DRUG IS PRESCRIBED | 11,9 | 10,2 |
THERAPEUTIC DUPLICATION | 10,2 | 8,8 |
MEDICATION PRESCRIBED INAPPROPRIATELY FOR A PARTICULAR CONDITION | 9,8 | 18,6 |
LENGTH | 9,0 | 21,3 |
SEQUENCIAL THERAPY | 7,2 | 0 |
SCHEDULE | 6,5 | 2,5 |
INAPPROPRIATE DOSE | 5,8 | 3,6 |
LACK OF UNDERSTANDING OF THE MEDICATION | 5,6 | 1,68 |
DOSAGE FORM | 3,5 | 0,14 |
ROUTE OF ADMINISTRATION | 3,1 | 0,1 |
MEDICATION WITH NO INDICATION | 3,0 | 15,5 |
METHOD OF ADMINISTRATION | 2,7 | 0,1 |
DRUG-NUTRIENT THAT ARE CLINICALLY SIGNIFICANT | 2,3 | 0 |
INAPPROPRIATE DOSE IR | 1,9 | 2,7 |
ACTUAL AND POTENCTIAL DRUG-DRUG THAT ARE CLINICALLY SIGNIFICANT | 1,4 | 0,5 |
ACTUAL AND POTENTIAL ADVERSE DRUG EVENTS | 0,9 | 2,5 |
FAILURE TO RECEIVE THE FULL BENEFIT OF PRESCRIBED THERAPY | 0,4 | 2,86 |
DRUG-DISEASE THAT ARE CLINICALLY SIGNIFICANT | 0,1 | 1,28 |